Partial hepatectomy enhances the growth of CC531 rat colorectal cancer cells both in vitro and in vivo
Open Access
- 8 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-9
- https://doi.org/10.1038/s41598-021-85082-z
Abstract
Partial hepatectomy (PHx) is the gold standard for the treatment of colorectal cancer liver metastases. However, after removing a substantial amount of hepatic tissue, growth factors are released to induce liver regeneration, which may promote the proliferation of liver micrometastases or circulating tumour cells still present in the patient. The aim of this study is to assess the effect of PHx on the growth of liver metastases induced by intrasplenic cell inoculation as well as on in vitro proliferation of the same cancer cell line. Liver tumours were induced in 18 WAG/RijHsd male rats, by seeding 250,000 syngeneic colorectal cancer cells (CC531) into the spleen. The left lateral lobe of the liver was mobilized and in half of the animals it was removed to achieve a 40% hepatectomy. Twenty-eight days after tumour induction, the animals were sacrificed and the liver was removed and sliced to assess the relative tumour surface area (RTSA%). CC531 cells were cultured in presence of foetal calf serum, non-hepatectomised (NRS) or hepatectomized rat serum (HRS), and their proliferation rate at 24, 48, and 72 h was measured. RTSA% was significantly higher in animals which had undergone PHx than in the controls (non-hepatectomised) (46.98 ± 8.76% vs. 18.73 ± 5.65%; p < 0.05). Analysing each lobe separately, this difference in favour of hepatectomized animals was relevant and statistically significant in the paramedian and caudate lobes. But in the right lobe the difference was scarce and not significant. In vitro, 2.5% HRS achieved stronger proliferative rates than the control cultures (10% FCS) or their equivalent of NRS. In this experimental model, a parallelism has been shown between the effect of PHx on the growth of colorectal cancer cells in the liver and the effect of the serum on those cells in vitro.Funding Information
- Basque Association for Surgical Research
- Scientific Foundation of the Spanish Association Against Cancer
This publication has 52 references indexed in Scilit:
- Increased growth of colorectal liver metastasis following partial hepatectomyClinical & Experimental Metastasis, 2013
- Effect on Outcome of Recurrence Patterns After Hepatectomy for Colorectal MetastasesAnnals of Surgical Oncology, 2010
- Growth factor regulation of proliferation and survival of multipotential stromal cellsStem Cell Research & Therapy, 2010
- An in vivo rat model for early development of colorectal cancer metastasis to liverInternational Journal of Experimental Pathology, 2008
- In vivo models for early development of colorectal liver metastasisInternational Journal of Experimental Pathology, 2007
- Predictors of survival after hepatic resection among patients with colorectal liver metastasisBritish Journal of Cancer, 2007
- Murine Models to Evaluate Novel and Conventional Therapeutic Strategies for CancerThe American Journal of Pathology, 2007
- Epidemiology and Management of Liver Metastases From Colorectal CancerAnnals of Surgery, 2006
- Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude miceEuropean Journal of Cancer, 2004
- Dormant liver metastases: an experimental studyBritish Journal of Surgery, 1992